Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference45 articles.
1. Biology calls the targets: combining RNAi and disease biology;H van Es;Drug Discov Today,2005
2. A large-scale RNAi screen in human cells identifies new components of the p53 pathway;K Berns;Nature,2004
3. Expression profiling reveals off-target gene regulation by RNAi;AL Jackson;Nat Biotechnol,2003
4. Transcription factor GATA1 is dispensable for mast cell differentiation in adult mice;K Ohneda;Mol Cell Biol,2014
5. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering;T Gaj;Trends Biotechnol,2013
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles;Frontiers in Immunology;2024-08-30
2. Advancements in Gene Therapy for Type 2 Diabetes: Insights from CRISPR Cas9 Mediated Gene Editing and Insulin Production;Pharmaceutical Science;2024-05-29
3. dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer;The CRISPR Journal;2024-04-01
4. Generation of CRISPR-Cas9-mediated knockin mutant models in mice and MEFs for studies of polymorphism in clock genes;Scientific Reports;2023-05-19
5. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications;International Journal of Biological Macromolecules;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3